Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis

被引:26
作者
Bensi, C. [1 ]
Marrodan, M. [1 ]
Gonzalez, A. [2 ]
Chertcoff, A. [3 ]
Osa Sanz, E. [4 ]
Chaves, H. [4 ]
Schteinschnaider, A. [5 ]
Correale, J. [1 ,6 ]
Farez, M. F. [6 ,7 ]
机构
[1] Inst Neurol Res Dr Raul Carrea FLENI, Dept Neurol, Buenos Aires, DF, Argentina
[2] HIBA, Dept Neuropediat, Buenos Aires, DF, Argentina
[3] Hosp Britanico Buenos Aires, Dept Neurol, Buenos Aires, DF, Argentina
[4] Inst Neurol Res Dr Raul Carrea FLENI, Dept Diagnost Imaging, Buenos Aires, DF, Argentina
[5] Inst Neurol Res Dr Raul Carrea FLENI, Dept Neuropediat, Buenos Aires, DF, Argentina
[6] Inst Neurol Res Dr Raul Carrea FLENI, Ctr Res Neuroimmunol Dis CIEN, Montaneses 2325, Buenos Aires, DF, Argentina
[7] Inst Neurol Res Dr Raul Carrea FLENI, Ctr Biostat Epidemiol & Publ Hlth CEBES, Buenos Aires, DF, Argentina
关键词
Neuromyelitis optica; Neuromyelitis optica spectrum disorders; Multiple sclerosis; MOG; SPECTRUM; NMO; MS;
D O I
10.1016/j.msard.2018.08.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Test the ability of a brain and spinal cord MRI criteria to differentiate neuromyelitis optica spectrum disorders and MOG-disease from MS. MRI criteria was further tested in patients with CIS and pediatric MS. Background: MOG-disease and neuromyelitis optica spectrum disorders can present clinical and radiological features strikingly similar to those of MS. Previously, diagnostic criteria based on brain MRI have been proposed to distinguish between these demyelinating diseases (Matthews-Jurynczik criteria), but spinal cord imaging and its relevance in CIS have not been evaluated. Simple brain and spinal cord MRI criteria may help separate these three inflammatory CNS diseases both in adults and children, aiding in early diagnostic decision-making, such as need for antibody testing. Design/methods: We included 150 participants (23 with aquaporin-4-positive neuromyelitis optica spectrum disorder, 14 with MOG-disease, 20 with aquaporin-4-negative neuromyelitis optica spectrum disorder, 48 with adult-onset relapsing remitting MS, 24 with pediatric-onset MS and 21 with clinically isolated syndrome). Brain and spinal cord MRI scans were anonymised and scored by 2 separate raters, based on two sets of criteria: one previously described by Matthews and colleagues (including presence of at least one lesion adjacent to the body of lateral ventricle and in the inferior temporal lobe, or presence of subcortical U-fiber lesion or a Dawson's finger-type lesion), and an extended version including spinal cord features (non-longitudinally extensive cervical lesion). Results: Extended MRI brain and spinal cord lesion criteria were able to separate adult-onset relapsing remitting MS with 100% sensitivity and 87% specificity from aquaporin-4-positive neuromyelitis optica spectrum disorder; and with 100% sensitivity and 79% specificity from MOG-disease. Additionally, brain and spinal cord criteria showed 100% sensitivity and specificity in patients presenting optic neuritis. Brain and spinal cord criteria were less sensitive in patients with CIS and in pediatric MS patients. Conclusions: Our data suggest radiological criteria can be useful to separate MS from MOG- and aquaporin-4-positive neuromyelitis optica spectrum disorders, in particular in patients with optic neuritis. Further work is needed to support their use in CIS.
引用
收藏
页码:246 / 250
页数:5
相关论文
共 14 条
  • [1] [Anonymous], J NEUROINFLAMM
  • [2] Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults The MOGADOR study
    Cobo-Calvo, Alvaro
    Ruiz, Anne
    Maillart, Elisabeth
    Audoin, Bertrand
    Zephir, Helene
    Bourre, Bertrand
    Ciron, Jonathan
    Collongues, Nicolas
    Brassat, David
    Cotton, Francois
    Papeix, Caroline
    Durand-Dubief, Francoise
    Laplaud, David
    Deschamps, Romain
    Cohen, Mikael
    Biotti, Damien
    Ayrignac, Xavier
    Tilikete, Caroline
    Thouvenot, Eric
    Brochet, Bruno
    Dulau, Cecile
    Moreau, Thibault
    Tourbah, Ayman
    Lebranchu, Pierre
    Michel, Laure
    Lebrun-Frenay, Christine
    Montcuquet, Alexis
    Mathey, Guillaume
    Debouverie, Marc
    Pelletier, Jean
    Labauge, Pierre
    Derache, Nathalie
    Coustans, Marc
    Rollot, Fabien
    De Seze, Jerome
    Vukusic, Sandra
    Marignier, Romain
    [J]. NEUROLOGY, 2018, 90 (21) : E1858 - E1869
  • [3] DISTRIBUTIONAL PATTERNS OF MULTIPLE-SCLEROSIS BRAIN-LESIONS - MAGNETIC-RESONANCE-IMAGING - CLINICAL CORRELATION
    GONZALEZ, CF
    SWIRSKYSACCHETTI, T
    MITCHELL, D
    LUBLIN, FD
    KNOBLER, RL
    EHRLICH, SM
    [J]. JOURNAL OF NEUROIMAGING, 1994, 4 (04) : 188 - 195
  • [4] Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis
    Hyun, Jae-Won
    Huh, So-Young
    Shin, Hyun-June
    Woodhall, Mark
    Kim, Su-Hyun
    Irani, Sarosh R.
    Lee, Sang Hyun
    Waters, Patrick
    Kim, Ho Jin
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (04) : 585 - 590
  • [5] MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin
    Jarius, Sven
    Ruprecht, Klemens
    Kleiter, Ingo
    Borisow, Nadja
    Asgari, Nasrin
    Pitarokoili, Kalliopi
    Pache, Florence
    Stich, Oliver
    Beume, Lena-Alexandra
    Huemmert, Martin W.
    Trebst, Corinna
    Ringelstein, Marius
    Aktas, Orhan
    Winkelmann, Alexander
    Buttmann, Mathias
    Schwarz, Alexander
    Zimmermann, Hanna
    Brandt, Alexander U.
    Franciotta, Diego
    Capobianco, Marco
    Kuchling, Joseph
    Haas, Juergen
    Korporal-Kuhnke, Mirjam
    Lillevang, Soeren Thue
    Fechner, Kai
    Schanda, Kathrin
    Paul, Friedemann
    Wildemann, Brigitte
    Reindl, Markus
    [J]. JOURNAL OF NEUROINFLAMMATION, 2016, 13
  • [6] Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
    Jurynczyk, Maciej
    Tackley, George
    Kong, Yazhuo
    Geraldes, Ruth
    Matthews, Lucy
    Woodhall, Mark
    Waters, Patrick
    Kuker, Wilhelm
    Craner, Matthew
    Weir, Andrew
    DeLuca, Gabriele C.
    Kremer, Stephane
    Leite, Maria Isabel
    Vincent, Angela
    Jacob, Anu
    de Seze, Jerome
    Palace, Jacqueline
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (02) : 132 - 136
  • [7] Kim S. M., 2015, NEUROLOGY, V2, P1
  • [8] Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
    Kleiter, Ingo
    Hellwig, Kerstin
    Berthele, Achim
    Kuempfel, Tania
    Linker, Ralf A.
    Hartung, Hans-Peter
    Paul, Friedemann
    Aktas, Orhan
    [J]. ARCHIVES OF NEUROLOGY, 2012, 69 (02) : 239 - 245
  • [9] Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution
    Matthews, Lucy
    Marasco, Rita
    Jenkinson, Mark
    Kueker, Wilhelm
    Luppe, Sebastian
    Leite, Maria Isabel
    Giorgio, Antonio
    De Stefano, Nicola
    Robertson, Neil
    Johansen-Berg, Heidi
    Evangelou, Nikos
    Palace, Jacqueline
    [J]. NEUROLOGY, 2013, 80 (14) : 1330 - 1337
  • [10] Interferon Beta Treatment in Neuromyelitis Optica Increase in Relapses and Aquaporin 4 Antibody Titers
    Palace, Jacqueline
    Leite, Maria Isabel
    Nairne, Angela
    Vincent, Angela
    [J]. ARCHIVES OF NEUROLOGY, 2010, 67 (08) : 1016 - 1017